| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $337 | — | +0.0% |
| Operating Income | -$75K | +4.7% | -29.4% |
| Pre-tax Income | $25K | +135.9% | +142.3% |
| Net Income | $25K | +135.9% | +142.3% |
| EPS (Basic) | $0.00 | +131.3% | +135.7% |
| EPS (Diluted) | $0.00 | +112.5% | +114.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13K | -65.0% | — |
| Current Assets | $20K | -55.6% | — |
| Total Assets | $432.3M | -0.0% | — |
| Current Liabilities | $5.0M | +0.0% | — |
| Total Liabilities | $5.0M | -2.8% | — |
| Stockholders' Equity | $427.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$247K | — | — |
| Capital Expenditures | $20K | — | — |
| Investing Cash Flow | -$45K | — | — |
| Financing Cash Flow | $296K | — | — |
| Free Cash Flow | -$267K | — | — |
| +0.0% |
| — |